Denali Therapeutics Inc. (DNLI)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
20.81
2.07 (11.05%)
At close: Jan 15, 2025, 12:42 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
PE Ratio | -20.3 | -10.71 | -18.65 | 128.31 | -8.43 | -52.8 | -2.65 | -1.59 | -3.84 |
PS Ratio | 8.92 | 32.19 | 111.38 | 27.19 | 62.43 | 14.82 | n/a | n/a | n/a |
PB Ratio | 2.86 | 3.35 | 5.63 | 7.93 | 4.22 | 3.50 | 0.50 | 0.54 | -4.12 |
P/FCF Ratio | -7.95 | -13.3 | -24.65 | 22.10 | -9.83 | 40.96 | -2.94 | -1.76 | -3.56 |
P/OCF Ratio | -8.23 | -14.27 | -25.64 | 21.93 | -10.99 | 38.18 | -3.05 | -1.9 | -4.28 |
OCF/S Ratio | -1.08 | -2.26 | -4.34 | 1.24 | -5.68 | 0.39 | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.06 | 0.06 | 0.06 | 0.17 | n/a | n/a | n/a | n/a |
Quick Ratio | 13.65 | 3.78 | 2.37 | 20.86 | 9.48 | 14.93 | 28.95 | 19.98 | 9.60 |
Current Ratio | 13.65 | 3.77 | 2.37 | 20.86 | 9.48 | 14.67 | 28.92 | 19.98 | 9.60 |
Asset Turnover | 0.29 | 0.07 | 0.03 | 0.21 | 0.05 | 0.20 | n/a | n/a | n/a |
Interest Coverage | n/a | -23.06 | n/a | n/a | -14.01 | n/a | -46.11 | n/a | -153.02 |
Return on Equity (ROE) | -0.14 | -0.31 | -0.3 | 0.06 | -0.5 | -0.07 | -0.19 | -0.34 | 1.07 |
Return on Assets (ROA) | -0.13 | -0.22 | -0.21 | 0.04 | -0.36 | -0.05 | -0.18 | -0.32 | -0.46 |
Return on Capital (ROIC) | -0.18 | -0.31 | -0.29 | 0.04 | -0.42 | -0.07 | -0.19 | -0.33 | -0.5 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 94.94% | 93.52% | 88.47% | 36.66% | -624.87% | 94.26% | n/a | n/a | n/a |
Net Profit Margin | -43.94% | -300.56% | -597.15% | 21.19% | -740.74% | -28.06% | n/a | n/a | n/a |
Pretax Profit Margin | -43.93% | -300.54% | -598.34% | 21.44% | -742.05% | -28.06% | n/a | n/a | n/a |
Operating Profit Margin | -59.51% | -314.16% | -607.78% | 18.69% | -799.1% | -35.9% | n/a | n/a | n/a |
FCF Margin | -112.22% | -242.06% | -451.88% | 123.06% | -635.34% | 36.17% | n/a | n/a | n/a |
EBITDA Margin | -54.45% | -304.58% | -590.12% | 18.69% | -769.15% | -30.16% | n/a | n/a | n/a |